Annual Meeting News

See the latest annual meeting press releases. Read about schedules, agendas, outcomes, and significant decisions. Browse annual meeting announcements for insights from leading companies.

Mar 17, 2026 at 4:44 PM

Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancers

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced it will present new long-term AVMAPKI™ FAKZYNJA™ combination therapy (avutometinib capsules; defactinib tablets) data from the Phase 2 RAMP 201 clinical trial at the Society of Gynecologic Oncology (SGO) 2026 Annual Meeting on Women’s Cancers. Additional abstracts accepted for presentation will also be shar...
Mar 17, 2026 at 4:30 PM

Orum Therapeutics to Present New Preclinical Data on ORM-1153, a CD123-Targeting Degrader Antibody Conjugate, at the AACR Annual Meeting 2026

BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--Orum Therapeutics to Present New Preclinical Data on ORM-1153, a CD123-Targeting Degrader Antibody Conjugate, at the AACR Annual Meeting 2026...
Mar 17, 2026 at 4:30 PM

Onchilles Pharma to Present New Preclinical Data on Systemically Delivered NEU-002 Program at AACR 2026

SAN DIEGO--(BUSINESS WIRE)--Onchilles Pharma to Present New Preclinical Data on Systemically Delivered NEU-002 Program at AACR 2026...
Mar 17, 2026 at 12:45 PM

Mauna Kea Technologies Updates Its Financial Calendar

PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces the update of its financial calendar for the 2026 fiscal year. Events Date Q1 2026 Sales April 15, 2026 2025 Annual Results April 22, 2026 2026 Annual General Meeting June 4, 2026 Q2 2026 Sales July 21, 2026 2026 Half-Year Results October 8, 2026 Q3 2026 Sales Octob...
Mar 17, 2026 at 9:15 AM

Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance

LOS ANGELES--(BUSINESS WIRE)--Altai Capital Management, L.P. ("Altai"), one of the largest shareholders and the beneficial owners of approximately 5% of the outstanding common stock of OraSure Technologies, Inc. (“OraSure” or the “Company”) (NASDAQ: OSUR), today announced that it has delivered a letter to the OraSure Board of Directors (the “Board”) outlining a five-pillar case for why change is necessary to preserve and deliver value for its investors. In the letter, Altai calls on the OraSure...
Mar 16, 2026 at 11:14 AM

Everybody Loves Languages Corp. Provides Supplemental and Amending Disclosure on Proposed Acquisition by ELL Ventures Ltd. and Reschedules Meeting

TORONTO--(BUSINESS WIRE)--Everybody Loves Languages Corp. ("ELL" or the "Company") (TSX-V: ELL; OTC: LMDCF; FSE: LIMA), www.everybodyloveslanguages.com, an edtech language learning edutainment and content development company, today announces that further to its press release of February 27, 2026, the Company is providing additional disclosure to supplement and amend the disclosure in the information circular (the "Circular") for the annual general and special meeting to now be held on Thursday,...
Mar 16, 2026 at 9:00 AM

Dream Chasers Reveals Shocking Details of Secret Carver Board Dilution Deal Code-Named “Project George”

NEW YORK--(BUSINESS WIRE)--Dream Chasers, the leading shareholder of Carver Bancorp, Inc. (OTCQB: CARV), is publicly disclosing a secret, unauthorized share sale code-named “Project George.” Dream Chasers is acting to protect market integrity and ensure all shareholders are treated with transparency. Dream Chasers uncovered Project George after Carver management mistakenly sent confidential emails disclosing plans to sell 524,826 shares—specifically a preferred-to-common conversion—to EJF Capit...
Mar 16, 2026 at 5:54 AM

Vivendi: Procedures for Obtaining or Consulting Information on the Combined General Shareholders’ Meeting to Be Held on April 21, 2026

PARIS--(BUSINESS WIRE)--Regulatory News: The Vivendi (Paris:VIV) Combined General Shareholders' Meeting will be held on Tuesday, April 21, 2026, at 10:00 am, at Casino de Paris, 16 rue de Clichy, 75009 Paris-France. The preliminary notice of meeting (avis préalable de réunion) containing the agenda and the draft resolutions was published (in French) in today's Bulletin des Annonces Légales Obligatoires. The preliminary notice also explains the terms and conditions for participating in and votin...
Mar 13, 2026 at 3:53 PM

Dream Chasers Responds to Carver Attempt to Block Bank Turnaround Expert Moishe Gubin

NEW YORK--(BUSINESS WIRE)--Dream Chasers Capital Group (DCCG), the leading shareholder of Carver Bancorp, Inc. (OTCQB: CARV), is today responding to the Board’s recent blocking of the nomination of Moishe Gubin, Chairman of NYSE-listed OptimumBank Holdings, Inc. (NASDAQ: OPHC), and Greg Lewis, CEO of Dream Chasers. Shareholders should not be surprised. Shareholders are once again witnessing the Board’s utilization of corporate machinery—backed by high-priced counsel—to disenfranchise owners thr...
Mar 13, 2026 at 9:05 AM

Carvana Board of Directors Approves 5 for 1 Forward Stock Split

PHOENIX--(BUSINESS WIRE)--Carvana (NYSE: CVNA), the industry pioneer for buying and selling cars online, today announced that its Board of Directors approved a 5 for 1 split of its common stock. The split is designed to ensure that earning and buying whole shares of Carvana stock is within reach for all of its team members. "This is the first split in Carvana’s history, and we believe it achieves the important goal of keeping our stock accessible to all of our team members," said Mark Jenkins,...
Turn Your News Into Headlines!
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up